TLMR News
Archived Headlines
- US IPO Recap: Ultragenyx doubles and Dicerna triples in home-run week for biotech IPOs 02/03/14
- WL Ross-backed Talmer Bancorp sets terms for $210 million IPO 01/31/14
- US IPO Recap: Twenty companies file or set terms for IPOs 01/13/14
- Midwestern bank Talmer Bancorp files for a $230 million IPO 01/10/14
US IPO Recap: Wave goodbye to the biotech wave as tech prepares to take over
Last week marked the end of the greatest amount of biotech activity across a two-week stretch in over a decade (14 pricings from 1/29 to 2/11). However, without any superstar performers like January’s Dicerna (DRNA; up 160%) or Ultragenyx (RARE; 110%),...read more
Health IPOs down 1% and housing IPOs trade up after heavy discount
The week’s five health sector IPOs have produced lackluster returns; together they are down 1% on average from their IPO prices. Amedica (AMDA), which creates improved spine, hip and joint replacements, dropped 6% today after pricing at the largest...read more
Midwest community bank Talmer Bancorp prices IPO at $13, within the range
Talmer Bancorp, a Wilbur Ross-backed regional bank with 94 branches in the Midwest, raised $202 million by offering 15.6 million shares (76% insider) at $13, within the range of $12.50 to $14.50. At the offer price, the company commands a market cap of...read more
9 US IPOs planned for the week of Feb 10
The following IPOs are expected to price this week: Amedica (AMDA), which develops and sells medical devices using its silicon nitride technology platform, plans to...read more